Ustekinumab
HealthData.Gov
Updated Mar 23, 2026
About this dataset
Stelara (ustekinumab) is a prescription biologic medication that blocks interleukin-12 and interleukin-23 to reduce inflammation. It's given as subcutaneous injections in 45 mg/0.5 mL or 90 mg/mL doses, manufactured by Janssen Biotech, Inc., and approved under BLA125261. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Ustekinumab
Access the FDA dataset for Ustekinumab — ANDA 125261 submitted by Mylan Institutional LLC
Modified Mar 23, 2026